11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
On February 20, 2020, the Puerto Rico Treasury Department (PR Treasury) issued Internal Revenue Circ...
Read More >
New York employers – New York State has gifted you an early holiday present – a requirement to upd...
Read More >
If you’re an employer in Maryland, beginning October 1, 2019, you are prohibited from requiring a l...
Read More >
As part of an analysis, Fidelity Investments compared average asset allocations of participants to a...
Read More >
International Construction Arbitration has received a shock. Consistent with the leading textbooks, ...
Read More >
With Super Tuesday coming up on March 3, 2020, it’s smart for employers to have a plan on how to ha...
Read More >